Source:http://linkedlifedata.com/resource/pubmed/id/12915459
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
19
|
| pubmed:dateCreated |
2003-9-16
|
| pubmed:abstractText |
Transgenic Drosophila expressing human alpha-synuclein faithfully replicate essential features of human Parkinson's disease, including age-dependent loss of dopaminergic neurons, Lewy-body-like inclusions and locomotor impairment. To define the transcriptional program encoding molecular machinery involved in alpha-synuclein pathology, we characterized expression of the entire Drosophila genome at pre-symptomatic, early and advanced disease stages. Fifty-one signature transcripts, including lipid, energy and membrane transport mRNAs, were tightly associated with alpha-synuclein expression. Most importantly, at the pre-symptomatic stage, when the potential for neuroprotection is greatest, expression changes revealed specific pathology. In age-matched tau transgenic Drosophila, the transcription of alpha-synuclein associated genes was normal, suggesting highly distinct pathways of neurodegeneration. Temporal profiling of progressive gene expression changes in neurodegenerative disease models provides unbiased starting points for defining disease mechanisms and for identifying potential targets for neuroprotective drugs at pre-clinical stages.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Nerve Tissue Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/SNCA protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Synucleins,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-Synuclein,
http://linkedlifedata.com/resource/pubmed/chemical/tau Proteins
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
0964-6906
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
1
|
| pubmed:volume |
12
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2457-66
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:12915459-Animals,
pubmed-meshheading:12915459-Animals, Genetically Modified,
pubmed-meshheading:12915459-Disease Models, Animal,
pubmed-meshheading:12915459-Drosophila,
pubmed-meshheading:12915459-Gene Expression,
pubmed-meshheading:12915459-Gene Expression Profiling,
pubmed-meshheading:12915459-Genome,
pubmed-meshheading:12915459-Humans,
pubmed-meshheading:12915459-Lewy Bodies,
pubmed-meshheading:12915459-Mutation,
pubmed-meshheading:12915459-Nerve Degeneration,
pubmed-meshheading:12915459-Nerve Tissue Proteins,
pubmed-meshheading:12915459-Parkinson Disease,
pubmed-meshheading:12915459-Polymerase Chain Reaction,
pubmed-meshheading:12915459-Synucleins,
pubmed-meshheading:12915459-Time Factors,
pubmed-meshheading:12915459-Transcription, Genetic,
pubmed-meshheading:12915459-Transgenes,
pubmed-meshheading:12915459-alpha-Synuclein,
pubmed-meshheading:12915459-tau Proteins
|
| pubmed:year |
2003
|
| pubmed:articleTitle |
Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease.
|
| pubmed:affiliation |
Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Cambridge, MA 02139, USA.
|
| pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|